In the UK chronic gastrointestinal symptoms after cancer therapies have a similar impact as IBD. However, in contrast to patients with IBD, most of these patients won’t see a gastroenterologist. In this month’s Gut Editor’s Choice the causes of these side effects of cancer treatment are discussed, as well as the benefits of investigation and treatment.

In this podcast Mairi McLean, senior clinical lecturer and consultant in gastroenterology at the University of Aberdeen talks to some key stakeholders in this issue:

Professor Sir Mike Richards, national clinical director for cancer and end of life care, Department of Health
Jane Maher, chief medical officer for McMillian Cancer Support
Jon Rhodes, professor of gastroenterology and president of the British Society of Gastroenterology
Jervoise Andeyev, consultant gastroenterologist in pelvic radiation disease at the Royal Marsden NHS Trust, London

See also:
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer